FindTrial
Sign In

The Impact of Liver Fibrosis Score on the Prognosis of Heart Failure Patients

The Impact of Liver Fibrosis Score on the Prognosis of Heart Failure Patients: A Single-Center, Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116263
Enrollment
Unknown
Registered
2026-01-07
Start date
2026-01-07
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Observation group:N/A

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.hospitalized patients with acute/chronic heart failure meeting the diagnostic criteria of the "Chinese Guidelines for the Diagnosis and Treatment of Heart Failure"; 3.complete baseline (within 24 hours of admission) liver function (ALT, AST, PLT) and renal function test records available in our hospital for calculating liver fibrosis scores.

Exclusion criteria

Exclusion criteria: 1.Patients with severely incomplete clinical data, making it impossible to calculate key scores or determine endpoint events; 2.Those with acute hepatitis, decompensated cirrhosis, liver cancer, or other active liver diseases; 3.Those with severe hematologic diseases, advanced malignant tumors, or other non-cardiac diseases with an expected lifespan of <1 year; 4.Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Composite endpoint: 1-year all-cause mortality or heart failure rehospitalization rate (either event occurring is counted as an endpoint event);;—

Countries

China

Contacts

Public ContactGaigai Ma

Xi'an Jiaotong University Second Affiliated Hospital

magaigai@xjtu.edu.cn+86 29 8632 0430

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026